Autologous bone graft
Sponsors
Vericel Corporation, BioMimetic Therapeutics, Northern Orthopaedic Division, Denmark, Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, UMC Utrecht
Conditions
ACLAlveolar Bone AtrophyArthritisBone Degenerative ChangesCongenital DeformityDegenerative Disc DiseaseDegenerative Disorder of BoneDegenerative Joint Disease
Phase 1
Phase 2
Clinical Trial Based on the Use of Mononuclear Cells From Autologous Bone Marrow in Patients With Pseudoarthrosis
CompletedNCT01813188
Start: 2011-04-30End: 2014-06-30Updated: 2017-03-30
KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion
NCT04294004
Start: 2020-08-27End: 2025-07-30Updated: 2023-08-09
Phase 3
Unknown Phase
Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions
CompletedNCT01305356
Start: 2011-03-31End: 2014-04-30Updated: 2018-12-26
RCT of AttraX® Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion
CompletedNCT01982045
Start: 2013-10-31End: 2018-08-31Updated: 2019-02-05
MagnetOs™ Granules vs. Autograft in Instrumented Posterolateral Spinal Fusion
CompletedNCT03625544
Start: 2018-07-04End: 2024-10-07Updated: 2024-12-11
The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
CompletedNCT04533880
Start: 2020-08-31End: 2023-07-07Updated: 2024-08-13